We use cookies, including third-party cookies from Google to serve personalized ads through AdSense, to operate this site and understand how it is used. By continuing to browse, you accept this use. See our Privacy Policy and Terms of Use for details, including how to opt out of personalized advertising.
Accept
Health Works CollectiveHealth Works CollectiveHealth Works Collective
  • Health
    • Mental Health
  • Policy and Law
    • Global Healthcare
    • Medical Ethics
  • Medical Innovations
  • News
  • Wellness
  • Tech
Search
© 2023 HealthWorks Collective. All Rights Reserved.
Reading: Pharma Is from Mars, Patients Are from Venus
Share
Notification Show More
Font ResizerAa
Health Works CollectiveHealth Works Collective
Font ResizerAa
Search
Follow US
  • About
  • Contact
  • Privacy
© 2023 HealthWorks Collective. All Rights Reserved.
Health Works Collective > Policy & Law > Medical Education > Pharma Is from Mars, Patients Are from Venus
Medical EducationSocial MediaWellness

Pharma Is from Mars, Patients Are from Venus

Paul Tunnah
Paul Tunnah
Share
6 Min Read
pharmaphorum
SHARE

pharmaphorumAs the pharmaceutical industry faces increasing pressure to be more patient-centric, ensuring sufficient focus on the ultimate end consumer for medicines is starting to permeate into every aspect of its business, or so it would seem if you believe what is being said.

pharmaphorumAs the pharmaceutical industry faces increasing pressure to be more patient-centric, ensuring sufficient focus on the ultimate end consumer for medicines is starting to permeate into every aspect of its business, or so it would seem if you believe what is being said.

At one of the industry’s biggest commercial conferences last week, the patient was mentioned in almost every presentation, from junior marketers to C-level executives, and patients were present in significant numbers to also take part and quiz the industry representatives on their intentions.

While this all seems well-intentioned and genuine, it did flag one key problem for pharmaceutical companies in trying to engage with patients – they don’t speak the same language.

More Read

Tooth Decay Marielaina Perrone DDS
Is Your Child’s Education Affected By Tooth Decay?
The Top 5 Very Important Reasons To Learn CPR
Drug Cos. Using REMS to Delay Generic Competition
Find the Perfect Orthotic Device to Make Foot Pain Manageable
Personal or Population Health? Big Data or Small Data?

The world of pharmaceuticals, not unlike other sectors, is full of its own internal terminology – terms that we all use every day without thinking twice, but are utterly, utterly meaningless outside our own walls. For example, we have ‘multichannel marketing’, ‘key account management’, ‘closed-loop marketing’ and ‘salesforce effectiveness’ being bandied around as buzz words for more effective sales and marketing. But patients don’t want to be attacked via multiple channels, have closed-loop conversations or be managed more effectively – they want meaningful, genuine dialogue.

And it’s not just the patients that are confused by all this. Ask any doctor if they want to receive a ‘detail’ on a novel medication and they are likely to raise a slightly puzzled eyebrow. Or, as we’re speaking of details, ask them if the information you have about them in your ‘CRM’ system is up-to-date and see what reaction you get. CRM – is that some kind of new electronic prescribing system, clinical something-R, something-M perhaps?

It’s not just a problem on the commercial side of the industry either. The world of clinical trials and pharmacovigilance (drug safety to most people) is full of jargon. Within pharma, we talk about trial endpoints, whereas patients only know if they’re feeling better or not. And as for the language around unwanted side-effects from drugs, we talk about ‘adverse events’ in the same way that military commanders talk about ‘collateral damage’. To a patient, an adverse event could mean being doubled over being sick for hours on end, or worse, the end of their life. Suddenly, the term seems like a slight understatement.

While this creates challenges in direct engagement, it also hampers market research and social listening. If you want to find out what’s happening in diabetes, for example, you can’t just search for things like ‘diabetes’ and ‘diabetic retinopathy’, you need to search for things like ‘low blood sugar’, ‘losing vision’ and, if you really want to understand what patients are going through terms like ‘feeling scared’ and ‘depressed’ in association with diabetes.

Then we have popular areas such as medicines adherence – whether patients actually take their medicines – and personalised, or precision, medicine. On the former, patients certainly don’t like to ‘adhere’ to something they don’t understand and telling them their ‘compliance’ is not good enough sounds like something out of George Orwell’s 1984. On the latter, I was halfway through a round table debate once on personalised medicine when I realised that, for the patient in attendance, it had nothing to do with genetically-targeted therapies and everything to do with who treated them and how personal the service provided by the health system was.

And finally, we have the term ‘patient’ and the associated phrase of the moment, patient-centricity. Well here’s some news – most patients don’t refer to themselves as patients. They are people, living with a particular condition, with families, and friends, and jobs and lives to lead. And they just want to live long lives and have their condition impact their life as little as possible.

None of this is intended to be a whinge. Involving these people who are living with particular conditions more closely at every stage of pharmaceutical industry processes is absolutely vital – and they want to be involved for the most part too.

Just mind your language when you do so, or they might not understand a single word you say.

TAGGED:pharmapharmaphorum
Share This Article
Facebook Copy Link Print
Share

Stay Connected

1.5KFollowersLike
4.5KFollowersFollow
2.8KFollowersPin
136KSubscribersSubscribe

Latest News

The Nervous System Reset Guide: Simple Ways To Manage Stress -- AI-generated illustration
The Nervous System Reset Guide: Simple Ways To Manage Stress
Infographics Mental Health
November 14, 2026
Flat editorial illustration: A single digital quality-management platform connects document control, electronic approval, audit r
6 Best QMS Software Platforms for ISO 13485 and FDA Part 820 (QMSR)
Global Healthcare Policy & Law
November 12, 2026
Flat editorial illustration: Healthcare editorial illustration about accurate patient intake connecting registration, clinical re
The Role of Patient Data Accuracy in Healthcare Operations
Global Healthcare Policy & Law
November 11, 2026
Flat editorial illustration: Healthcare ethics-and-law training, shown through a coached clinical role-play where structured disc
Medical Ethics and the Law: The Training Behind Professionals Who Resolve Healthcare Disputes
Uncategorized
November 6, 2026

You Might also Like

Health Information Technology Online Seminar

August 29, 2011
LinkedIn social media for doctors
BusinesseHealthSocial Media

LinkedIn Cheat Sheet: Leverage the Executive Side of Social Media

January 14, 2014

Yanking Avastin’s Breast Cancer Indication –the Right Thing To Do

November 19, 2011
eHealthWellness

Anxious? Try These Healthcare Gadgets That Relieve Anxiety

June 19, 2019
Subscribe
Subscribe to our newsletter to get our newest articles instantly!
Follow US
© 2008-2026 HealthWorks Collective. All Rights Reserved.
  • About
  • Contact
  • Privacy
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?